Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A BOND

Showing results (651-660 of 682) with videos related to

Pageof 69
Sort By:
Blood Advances|September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapyDavid A Bond, Jeffrey M Switchenko, Diego Villa, et al.
Monthly Notices of the Royal Astronomical Society|August 28, 2020
The frequency of snowline-region planets from four-years of OGLE-MOA-Wise second-generation microlensingY Shvartzvald, D Maoz, A Udalski, et al.
NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.
Blood Advances|August 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesNarendranath Epperla, Adam S Zayac, Daniel J Landsburg, et al.
Immunity|June 24, 2022
SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infectionLouise C Rowntree, Thi H O Nguyen, Lukasz Kedzierski, et al.
Blood Advances|December 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphomaNarendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, et al.
American Journal of Hematology|March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centersKevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.
Cancer|October 1, 2019
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failureEmily C Ayers, Shaoying Li, L Jeffrey Medeiros, et al.
BMC Medicine|January 28, 2024
Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomesMaria Carolina Borges, Gemma L Clayton, Rachel M Freathy, et al.
Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Pageof 69

Showing results (651-660 of 682) with videos related to

Sort By:
Pageof 69
Blood Advances|September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapyDavid A Bond, Jeffrey M Switchenko, Diego Villa, et al.
Monthly Notices of the Royal Astronomical Society|August 28, 2020
The frequency of snowline-region planets from four-years of OGLE-MOA-Wise second-generation microlensingY Shvartzvald, D Maoz, A Udalski, et al.
NPJ Vaccines|October 6, 2025
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccinationRuth A Purcell, Marios Koutsakos, Lukasz Kedzierski, et al.
Blood Advances|August 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional seriesNarendranath Epperla, Adam S Zayac, Daniel J Landsburg, et al.
Immunity|June 24, 2022
SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infectionLouise C Rowntree, Thi H O Nguyen, Lukasz Kedzierski, et al.
Blood Advances|December 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphomaNarendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, et al.
American Journal of Hematology|March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centersKevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.
Cancer|October 1, 2019
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failureEmily C Ayers, Shaoying Li, L Jeffrey Medeiros, et al.
BMC Medicine|January 28, 2024
Integrating multiple lines of evidence to assess the effects of maternal BMI on pregnancy and perinatal outcomesMaria Carolina Borges, Gemma L Clayton, Rachel M Freathy, et al.
Blood Advances|March 12, 2021
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphomaReid W Merryman, Robert A Redd, Taiga Nishihori, et al.
Pageof 69